Literature DB >> 6432504

Hyperosmolarity response of ocular standing potential as a clinical test for retinal pigment epithelium activity. Normative data.

S Madachi-Yamamoto, D Yonemura, K Kawasaki.   

Abstract

The standing potential of the eye is decreased by intravenous administration of hypertonic solutions. This hyperosmolarity-induced response has been recorded in normal subjects by the use of electro-oculography (EOG) in the dark. An intravenous administration of Fructmanit (1.4 X 10(3) mOsmol) (150 approximately 500 ml, 2.37 approximately 9.70 ml/kg, 0.08 approximately 0.36 ml/kg/min) was used to evoke the hyperosmolarity response. The amplitude of the response was expressed in percentage, V0-Vmin/V0 X 100, where V0 is the base value of the EOG before administration of the hypertonic solution and Vmin is a minimum EOG amplitude after administration. The distribution of the amplitude of the hyperosmolarity response was approximated by the normal distribution in normal subjects. The minimum, the maximum, the mean and the standard deviation of the amplitude of the hyperosmolarity response were respectively 34.2%, 52.3%, 42.6% and 4.6% in normal subjects. The normal range of the hyperosmolarity response would be 33.4 approximately 51.8% (M +/- 2SD). The hyperosmolarity response, which originates mainly in the retinal pigment epithelium, is a useful new quantitative and specific test of the activity of the retinal pigment epithelium in clinical practice.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432504

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  4 in total

1.  Suppression of the hyperosmolarity response after cataract surgery.

Authors:  K Kawasaki; D Yonemura; T Yanagida; Y Segawa; K Wakabayashi; S Mukoh; H Ishida; S Fujii; Y Takahara
Journal:  Doc Ophthalmol       Date:  1986-11-15       Impact factor: 2.379

2.  Hyperosmolarity-induced hyperpolarization of the membrane potential of the retinal pigment epithelium.

Authors:  S Mukoh; K Kawasaki; D Yonemura; J Tanabe
Journal:  Doc Ophthalmol       Date:  1985-10-15       Impact factor: 2.379

3.  Hyperosmolarity response of ocular standing potential as a clinical test for retinal pigment epithelium activity diabetic retinopathy.

Authors:  K Kawasaki; D Yonemura; S Madachi-Yamamoto
Journal:  Doc Ophthalmol       Date:  1984-12-15       Impact factor: 2.379

4.  Corneal D.C. recordings of slow ocular potential changes such as the ERG c-wave and the light peak in clinical work. Equipment and examples of results.

Authors:  S E Nilsson; B E Andersson
Journal:  Doc Ophthalmol       Date:  1988 Mar-Apr       Impact factor: 2.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.